Kura Oncology, Inc. (KURA) stock
KURANasdaqPharmaceutical PreparationsFiscal year ends December 31
$7.34−0.15 (-2.00%)
Close on Nov 18, 2026Market cap $652.97MP/E –Yield –
Kura Oncology operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Kura Oncology's operating cash flow for the twelve months ending Sep 30, 2026 was -$85.57M, down 197.5% year over year. For fiscal 2025 it was -$64.06M, down 147.7% from the year before. The highest annual figure on record is $134.32M in fiscal 2024.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$64.06M | -147.7% |
| FY2024 | Dec 31, 2024 | $134.32M | – |
| FY2023 | Dec 31, 2023 | -$124.82M | – |
| FY2022 | Dec 31, 2022 | -$110.06M | – |
| FY2021 | Dec 31, 2021 | -$104.55M | – |
| FY2020 | Dec 31, 2020 | -$69.83M | – |
| FY2019 | Dec 31, 2019 | -$54.76M | – |
| FY2018 | Dec 31, 2018 | -$48.66M | – |
| FY2017 | Dec 31, 2017 | -$28.44M | – |
| FY2016 | Dec 31, 2016 | -$25.35M | – |
| FY2015 | Dec 31, 2015 | -$17.93M | – |
| FY2014 | Dec 31, 2014 | -$15.96K | – |
| FY2013 | Dec 31, 2013 | -$23.23K | – |
| FY2012 | Dec 31, 2012 | -$24.42K | – |
| FY2011 | Dec 31, 2011 | -$22.68K | – |
| FY2010 | Dec 31, 2010 | -$19.24K | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$54.44M | – |
| Q2 FY2026 | Jun 30, 2026 | -$62.55M | – |
| Q1 FY2026 | Mar 31, 2026 | -$85.85M | – |
| Q4 FY2025 | Dec 31, 2025 | $117.27M | -56.4% |
| Q3 FY2025 | Sep 30, 2025 | -$80.63M | – |
| Q2 FY2025 | Jun 30, 2025 | -$28.78M | – |
| Q1 FY2025 | Mar 31, 2025 | -$71.93M | – |
| Q4 FY2024 | Dec 31, 2024 | $269.13M | – |
| Q3 FY2024 | Sep 30, 2024 | -$43.44M | – |
| Q2 FY2024 | Jun 30, 2024 | -$42.53M | – |
| Q1 FY2024 | Mar 31, 2024 | -$48.84M | – |
| Q4 FY2023 | Dec 31, 2023 | -$34.31M | – |
| Q3 FY2023 | Sep 30, 2023 | -$29.03M | – |
| Q2 FY2023 | Jun 30, 2023 | -$25.62M | – |
| Q1 FY2023 | Mar 31, 2023 | -$35.87M | – |
| Q4 FY2022 | Dec 31, 2022 | -$26.53M | – |
| Q3 FY2022 | Sep 30, 2022 | -$21.01M | – |
| Q2 FY2022 | Jun 30, 2022 | -$30.34M | – |
| Q1 FY2022 | Mar 31, 2022 | -$32.18M | – |
| Q4 FY2021 | Dec 31, 2021 | -$23.37M | – |
| Q3 FY2021 | Sep 30, 2021 | -$24.59M | – |
| Q2 FY2021 | Jun 30, 2021 | -$28.07M | – |
| Q1 FY2021 | Mar 31, 2021 | -$28.52M | – |
| Q4 FY2020 | Dec 31, 2020 | -$18.31M | – |
| Q3 FY2020 | Sep 30, 2020 | -$16.97M | – |
| Q2 FY2020 | Jun 30, 2020 | -$14.73M | – |
| Q1 FY2020 | Mar 31, 2020 | -$19.82M | – |
| Q4 FY2019 | Dec 31, 2019 | -$13.93M | – |
| Q3 FY2019 | Sep 30, 2019 | -$12.15M | – |
| Q2 FY2019 | Jun 30, 2019 | -$14.43M | – |
| Q1 FY2019 | Mar 31, 2019 | -$14.25M | – |
| Q4 FY2018 | Dec 31, 2018 | -$10.21M | – |
| Q3 FY2018 | Sep 30, 2018 | -$13.00M | – |
| Q2 FY2018 | Jun 30, 2018 | -$12.59M | – |
| Q1 FY2018 | Mar 31, 2018 | -$12.85M | – |
| Q4 FY2017 | Dec 31, 2017 | -$7.47M | – |
| Q3 FY2017 | Sep 30, 2017 | -$6.24M | – |
| Q2 FY2017 | Jun 30, 2017 | -$6.11M | – |
| Q1 FY2017 | Mar 31, 2017 | -$8.62M | – |
| Q4 FY2016 | Dec 31, 2016 | -$6.74M | – |
See a number that looks wrong?